Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | CCR6 | P51684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38085 | 0.91 | — | — | |
| Water SCHEMBL28091835 | 0.89 | — | — | |
| Ammonia Solution, Strong SCHEMBL2328420 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL28905030 | 0.89 | — | — | |
| Benzene SCHEMBL27704544 | 0.87 | — | — | |
| SCHEMBL28549319 | 0.84 | GSK3A (0.42) | GSK3AGSK3BCCR6 | |
| Pyrrole SCHEMBL2280196 | 0.82 | — | — | |
| SCHEMBL28201436 | 0.82 | — | — | |
| SCHEMBL3695978 | 0.80 | — | — | |
| Carbamic Acid SCHEMBL28123766 | 0.80 | FGFR1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180263927-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC (US) | 2018-09-20 | — | — | US | claimed |
| US-9980926-B1 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2018-05-29 | — | — | US | claimed |
| US-10806708-B2 | Affinity medicant conjugate | AF CHEMICALS LLC (US) | 2020-10-20 | — | — | US | disclosed |
| US-10285955-B2 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2019-05-14 | — | — | US | disclosed |
| US-20180263927-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC (US) | 2018-09-20 | — | — | US | disclosed |
| US-9980926-B1 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-9381178-B2 | Affinity medicant conjugate | AF CHEMICALS LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160015658-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC | 2016-01-21 | — | — | US | disclosed |
| US-20150290152-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC | 2015-10-15 | — | — | US | disclosed |
| US-8921124-B2 | Pyrazole-based cyanine dye | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-30 | — | — | US | disclosed |
| WO-2012033298-A3 | METHOD FOR MANUFACTURING A NOX GAS SENSOR, AND NOX GAS SENSOR MANUFACTURED USING SAME | 일진머티리얼즈 주식회사 (KR) | 2012-05-10 | — | — | WO | disclosed |
| CN-1733721-A | Maleimide derivative and its preparation method and uses | DONG SHUYOU (CN) | 2006-02-15 | — | — | CN | disclosed |
| US-20050113304-A1 | Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins | ARMY, GOVERNMENT OF THE UNITED STATES DEPARTMENT OF THE ARMY (US) | 2005-05-26 | — | — | US | disclosed |
| US-20050008602-A1 | Oligopeptides for promoting hair growth | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2005-01-13 | — | — | US | disclosed |
| US-6573244-B1 | Compound in purified and isolated form or salts, esters, amides, and acyl forms thereof, selected from peptides having specified amino acid sequences | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2003-06-03 | — | — | US | disclosed |
| EP-1310511-A2 | Oligopeptides for promoting hair growth | Sumitomo Electric Industries, Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
| US-20030086893-A1 | Oligopeptides for promoting hair growth | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2003-05-08 | — | — | US | disclosed |
| WO-2000069891-A9 | PREVINS AS SPECIFIC INHIBITORS AND THERAPEUTIC AGENTS FOR BOTULINUM TOXIN B AND TETANUS NEUROTOXINS | DEPT OF THE ARMY (US) | 2002-07-04 | — | — | WO | disclosed |
| EP-1179010-A2 | PREVINS AS SPECIFIC INHIBITORS AND THERAPEUTIC AGENTS FOR BOTULINUM TOXIN B AND TETANUS NEUROTOXINS | U.S. Army Medical Research and Materiel Command (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000069891-A2 | PREVINS AS SPECIFIC INHIBITORS AND THERAPEUTIC AGENTS FOR BOTULINUM TOXIN B AND TETANUS NEUROTOXINS | DEPARTMENT OF THE ARMY (US) | 2000-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160015658-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | GSK3A 2180/4885GSK3B 2603/4885CCR6 291/4885 |
| US-20150290152-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | GSK3A 2180/4885GSK3B 2603/4885CCR6 291/4885 |
| US-10285955-B2 | Affinity medicant conjugate | FCER2, HDGF, FCGR2A | GSK3A 2180/4885GSK3B 2603/4885CCR6 291/4885 |
| US-20050008602-A1 | Oligopeptides for promoting hair growth | HDGF, HGF, AREG | GSK3A 2039/4885GSK3B 2043/4885CCR6 1140/4885 |
| US-10806708-B2 | Affinity medicant conjugate | FCER2, HDGF, FCGR2A | GSK3A 2180/4885GSK3B 2603/4885CCR6 291/4885 |
| US-20180263927-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | GSK3A 2180/4885GSK3B 2603/4885CCR6 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.